Skip to main content

Pinworm Medicine News

Impax Receives Approval of Emverm (mebendazole) Chewable Tablets

HAYWARD, Calif., Jan. 15, 2016 /PRNewswire/ – Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the United States Food and Drug Administration (FDA) has approved the Company's...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Pinworm Medicine patient information at Drugs.com